Metatranscriptome of human lung microbial communities in a cohort of mechanically ventilated COVID-19 Omicron patients.


Journal

Signal transduction and targeted therapy
ISSN: 2059-3635
Titre abrégé: Signal Transduct Target Ther
Pays: England
ID NLM: 101676423

Informations de publication

Date de publication:
10 Nov 2023
Historique:
received: 14 05 2023
accepted: 18 10 2023
revised: 21 09 2023
medline: 13 11 2023
pubmed: 11 11 2023
entrez: 10 11 2023
Statut: epublish

Résumé

The Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infected a substantial proportion of Chinese population, and understanding the factors underlying the severity of the disease and fatality is valuable for future prevention and clinical treatment. We recruited 64 patients with invasive ventilation for COVID-19 and performed metatranscriptomic sequencing to profile host transcriptomic profiles, plus viral, bacterial, and fungal content, as well as virulence factors and examined their relationships to 28-day mortality were examined. In addition, the bronchoalveolar lavage fluid (BALF) samples from invasive ventilated hospital/community-acquired pneumonia patients (HAP/CAP) sampled in 2019 were included for comparison. Genomic analysis revealed that all Omicron strains belong to BA.5 and BF.7 sub-lineages, with no difference in 28-day mortality between them. Compared to HAP/CAP cohort, invasive ventilated COVID-19 patients have distinct host transcriptomic and microbial signatures in the lower respiratory tract; and in the COVID-19 non-survivors, we found significantly lower gene expressions in pathways related viral processes and positive regulation of protein localization to plasma membrane, higher abundance of opportunistic pathogens including bacterial Alloprevotella, Caulobacter, Escherichia-Shigella, Ralstonia and fungal Aspergillus sydowii and Penicillium rubens. Correlational analysis further revealed significant associations between host immune responses and microbial compositions, besides synergy within viral, bacterial, and fungal pathogens. Our study presents the relationships of lower respiratory tract microbiome and transcriptome in invasive ventilated COVID-19 patients, providing the basis for future clinical treatment and reduction of fatality.

Identifiants

pubmed: 37949875
doi: 10.1038/s41392-023-01684-1
pii: 10.1038/s41392-023-01684-1
pmc: PMC10638395
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

432

Informations de copyright

© 2023. The Author(s).

Références

Viruses. 2020 Nov 01;12(11):
pubmed: 33139591
Nucleic Acids Res. 2017 Jan 4;45(D1):D581-D591
pubmed: 27903906
Innovation (Camb). 2021 Jul 01;2(3):100141
pubmed: 34557778
Bioinformatics. 2015 May 15;31(10):1674-6
pubmed: 25609793
Front Immunol. 2021 Jan 25;11:607734
pubmed: 33569053
Eur Respir J. 2018 Oct 4;52(4):
pubmed: 30190268
Ann Transl Med. 2020 Apr;8(7):504
pubmed: 32395548
Lancet Respir Med. 2022 Feb;10(2):e17
pubmed: 34929158
Gut. 2021 Apr;70(4):698-706
pubmed: 33431578
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Microbiome. 2022 Oct 5;10(1):165
pubmed: 36195943
Biomed Pharmacother. 2021 Aug;140:111785
pubmed: 34126316
Immunity. 2021 Nov 9;54(11):2450-2464
pubmed: 34758337
J Infect. 2020 Sep;81(3):e64-e67
pubmed: 32579991
Genome Biol. 2009;10(3):R25
pubmed: 19261174
Genome Biol. 2004;5(2):R12
pubmed: 14759262
Eur J Immunol. 2023 Jan;53(1):e2250010
pubmed: 36239164
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Med. 2021 Jul;27(7):1178-1186
pubmed: 33953384
Nature. 1992 Dec 3;360(6403):474-7
pubmed: 1448172
Helicobacter. 2003;8(5):521-32
pubmed: 14535999
Nature. 2017 Dec 7;552(7683):57-62
pubmed: 29186115
iScience. 2022 Sep 16;25(9):104926
pubmed: 35992303
Sci Bull (Beijing). 2023 Feb 15;68(3):295-304
pubmed: 36697300
PLoS Comput Biol. 2015 Dec 18;11(12):e1004557
pubmed: 26682918
Nat Commun. 2020 Oct 30;11(1):5493
pubmed: 33127906
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D325-8
pubmed: 15608208
mSystems. 2020 Oct 27;5(5):
pubmed: 33109753
Lancet Infect Dis. 2022 Aug;22(8):1116-1117
pubmed: 35738299
Cell Discov. 2021 Apr 13;7(1):23
pubmed: 33850111
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Lancet Respir Med. 2018 Oct;6(10):733-735
pubmed: 30076120
Gut Microbes. 2021 Jan-Dec;13(1):1-21
pubmed: 33678150
Nat Microbiol. 2021 Oct;6(10):1245-1258
pubmed: 34465900
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Int Immunopharmacol. 2021 Nov;100:108125
pubmed: 34543980
Signal Transduct Target Ther. 2021 Jul 7;6(1):255
pubmed: 34234112
Signal Transduct Target Ther. 2020 Jul 25;5(1):128
pubmed: 32712629
PLoS One. 2023 Sep 27;18(9):e0292017
pubmed: 37756299
Nature. 2021 Mar;591(7851):633-638
pubmed: 33627867
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
J Basic Microbiol. 2013 Jan;53(1):1-8
pubmed: 22359233
Adv Sci (Weinh). 2021 Dec;8(23):e2102593
pubmed: 34687159
Pneumonia (Nathan). 2021 Apr 25;13(1):5
pubmed: 33894790
Nat Rev Immunol. 2012 Mar 09;12(4):295-305
pubmed: 22402670
Lancet Microbe. 2021 Jul;2(7):e300-e310
pubmed: 35544166
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Nat Rev Microbiol. 2023 Apr;21(4):222-235
pubmed: 36385637
JAMA Netw Open. 2023 Aug 1;6(8):e2330877
pubmed: 37615984
Cell. 2021 Jan 7;184(1):149-168.e17
pubmed: 33278357
Nat Microbiol. 2022 Sep;7(9):1361-1375
pubmed: 35995842
Clin Rev Allergy Immunol. 2023 Feb;64(1):90-107
pubmed: 35044620
Infection. 2021 Feb;49(1):15-28
pubmed: 32860214
Bioinformatics. 2015 Jun 15;31(12):2032-4
pubmed: 25697820

Auteurs

Lin Wang (L)

College of Pulmonary & Critical Care Medicine, 8th Medical Center of Chinese PLA General Hospital, Beijing, 100091, China.

Jia-Bao Cao (JB)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.

Bin-Bin Xia (BB)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
University of Chinese Academy of Sciences, Beijing, 100049, China.

Yue-Juan Li (YJ)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
University of Chinese Academy of Sciences, Beijing, 100049, China.

Xuan Zhang (X)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
Faculty of Biological Science and Technology, Baotou Teacher's College, Baotou, 014030, China.

Guo-Xin Mo (GX)

College of Pulmonary & Critical Care Medicine, 8th Medical Center of Chinese PLA General Hospital, Beijing, 100091, China.

Rui-Juan Wang (RJ)

Department of Respiratory Medicine, PLA Strategic Support Force Medical Center, Beijing, 100101, China.

Si-Qi Guo (SQ)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.

Yu-Qing Zhang (YQ)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
University of Chinese Academy of Sciences, Beijing, 100049, China.

Kun Xiao (K)

College of Pulmonary & Critical Care Medicine, 8th Medical Center of Chinese PLA General Hospital, Beijing, 100091, China.

Guang-Fa Zhu (GF)

Department of Respiratory and Critical Care Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, 100029, China.

Peng-Fei Liu (PF)

College of Pulmonary & Critical Care Medicine, 8th Medical Center of Chinese PLA General Hospital, Beijing, 100091, China.

Li-Cheng Song (LC)

College of Pulmonary & Critical Care Medicine, 8th Medical Center of Chinese PLA General Hospital, Beijing, 100091, China.

Xi-Hui Ma (XH)

Respiratory Research Institute, Department of Pulmonary & Critical Care Medicine, Beijing Key Laboratory of OTIR, the 8th Medical Center of Chinese PLA General Hospital, Beijing, 100091, China.

Ping-Chao Xiang (PC)

Shougang hospital of Peking University, Beijing, 100144, China.

Jiang Wang (J)

College of Pulmonary & Critical Care Medicine, 8th Medical Center of Chinese PLA General Hospital, Beijing, 100091, China.

Yu-Hong Liu (YH)

College of Pulmonary & Critical Care Medicine, 8th Medical Center of Chinese PLA General Hospital, Beijing, 100091, China.

Fei Xie (F)

College of Pulmonary & Critical Care Medicine, 8th Medical Center of Chinese PLA General Hospital, Beijing, 100091, China.

Xu-Dong Zhang (XD)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
University of Chinese Academy of Sciences, Beijing, 100049, China.

Xiang-Xin Li (XX)

Department of Respiratory Medicine, Beijing Changping Hospital, Beijing, 102200, China.

Wan-Lu Sun (WL)

Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China.

Yan Cao (Y)

Pulmonary research institute, Senior Department of Respiratory and Critical Care Medicine, the 8th medical center of Chinese PLA general hospital, Beijing, 100091, China.

Kai-Fei Wang (KF)

College of Pulmonary & Critical Care Medicine, Chinese PLA General Hospital, Beijing, 100853, China.

Wen-Hui Zhang (WH)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
University of Chinese Academy of Sciences, Beijing, 100049, China.

Wei-Chao Zhao (WC)

Department of Respiratory Medicine, PLA Strategic Support Force Medical Center, Beijing, 100101, China.

Peng Yan (P)

China Aerospace Science & Industry Corporation 731 hospital, Beijing, 100074, China.

Ji-Chao Chen (JC)

Department of Respiratory and Critical Care Medicine, Aerospace Center Hospital, Beijing, 100049, China.

Yu-Wei Yang (YW)

Respiratory Research Institute, Department of Pulmonary & Critical Care Medicine, Beijing Key Laboratory of OTIR, the 8th Medical Center of Chinese PLA General Hospital, Beijing, 100091, China.

Zhong-Kuo Yu (ZK)

College of Pulmonary & Critical Care Medicine, 8th Medical Center of Chinese PLA General Hospital, Beijing, 100091, China.

Jing-Si Tang (JS)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.

Li Xiao (L)

Respiratory Research Institute, Department of Pulmonary & Critical Care Medicine, Beijing Key Laboratory of OTIR, the 8th Medical Center of Chinese PLA General Hospital, Beijing, 100091, China.

Jie-Min Zhou (JM)

Vision Medicals Center for Infectious Diseases, Guangzhou, 510700, China.

Li-Xin Xie (LX)

College of Pulmonary & Critical Care Medicine, 8th Medical Center of Chinese PLA General Hospital, Beijing, 100091, China. xielx301@126.com.

Jun Wang (J)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China. junwang@im.ac.cn.
University of Chinese Academy of Sciences, Beijing, 100049, China. junwang@im.ac.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH